In this randomized controlled trial, a tetrahydrocannabinol and cannabidiol extract improved chemotherapy-induced nausea and vomiting in participants with cancer, but it also led to side effects such as sedation, dizziness, and transient anxiety.
This Study Summary was published on October 31, 2024.
